A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease: Primary Results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II Study
J Am Coll Cardiol Krucoff et al.
51: 1543
Online Appendix
Online Appendix
Files in this Data Supplement:
|